Area of research
Oncology · Biotechnology
Research interest
Research focused on Glioblastoma and Vaccination, with related work in T-cell receptor, Computational biology, Flow cytometry. Notable publications include 'Actively personalized vaccination trial for newly diagnosed glioblastoma', 'Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival', and 'Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study'.
SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma
Actively personalized vaccination trial for newly diagnosed glioblastoma
Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
Thinking Outside the Gate: Single-Cell Assessments in Multiple Dimensions
Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining
Cryopreservation of <scp>MHC</scp> multimers: Recommendations for quality assurance in detection of antigen specific <scp>T</scp> cells
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival